Eyenovia Inc. Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: New York NY United States (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2016
NCT02946125
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Eyenovia Inc.